Equity Research Information Technology Services

Should You Buy IBEX Limited Stock in 2026?

By CirclFi Research Team · · 13/13 models active

According to the CirclFi Deep Alpha Valuation Engine, IBEX Limited (IBEX) stands out as one of the highest-quality businesses in our coverage universe, earning a Quality of Company score of 9.9/10. At a current price of $35.39 and a market capitalization of $474M, the core investment question is whether the stock offers a compelling entry point relative to its estimated intrinsic value.

The short answer: 5 of 13 CirclFi valuation models project upside for IBEX Limited (IBEX) at $35.39 — the model consensus leans bearish, with a Quality Score of 9.9/10 and Value-Trap risk of —/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 8 of 13 models suggest overvaluation — majority bearish
  • Quality Score: 9.9/10 — Excellent — top-tier fundamentals
  • Value Trap Risk: —/100 — Not scored
  • Fair Value Range: $8.26 – $178.70 (2063% spread)

Bullish Models

5 / 13

Bearish Models

8 / 13

Quality Score

9.9 /10

Excellent — top-tier fundamentals

Value Trap Risk

/100
Not scored

Not scored

Model Consensus

13 /13
Active Models

Avg. confidence: 42%

Investment Thesis

The Bull Case

Target: $178.70 (+404.9% upside)

  • According to the CirclFi Quality of Company (QOC) framework, IBEX Limited's quality score of 9.9/10 demonstrates the operational excellence that historically correlates with long-term shareholder value creation.
  • According to the CirclFi Deep Alpha Valuation Engine, the gap between the market price of $35.39 and the composite fair value of $42.07 implies +18.9% upside potential.
  • According to the CirclFi Deep Alpha Valuation Engine, the Markov DDM model targets a fair value of $178.70 (+404.9%), anchoring the bull case with a methodology that provides a differentiated analytical lens.
  • Industry tailwind: pricing power could provide meaningful support for IBEX Limited's revenue and margin trajectory in the Information Technology Services space.

The Bear Case

Target: $8.26 (-76.7%)

  • According to the CirclFi Deep Alpha Valuation Engine, the Dynamic NAV model sees the stock as overvalued with a fair value of $8.26 (-76.7%), suggesting that the market price embeds overly optimistic growth assumptions.
  • According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +481.6% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology.
  • Industry headwind: elongated sales cycles represents a meaningful risk for IBEX Limited and its Information Technology Services peers.

Peer Benchmarking

EXLS ExlService Holdings,
10.0
INOD Innodata Inc.
10.0
G Genpact Limited
10.0
IT Gartner, Inc.
9.9
JKHY Jack Henry & Associa
9.8

See full Information Technology Services rankings →

Valuation Divergence

Spread

2063%

Fair Value Range

$8.26 – $178.70

A 2063% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

Markov DDM

$178.70 (+404.9%)

Most Bearish

Dynamic NAV

$8.26 (-76.7%)

Key Risk Factors

Model Disagreement

2063% spread signals high variance in projections.

Bearish Consensus

8/13 models suggest overvaluation.

Macro/Sector Risk

Information Technology Services headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View IBEX Data Page →

The Bottom Line

Caution dominates our read on IBEX Limited at $35.39. 8 of 13 models see limited upside or outright downside, with the composite fair value at $42.07 (+18.9%). Quality at 9.9/10 provides some fundamental cushion. Current holders should re-evaluate their thesis; new buyers should demand a wider margin of safety.

These are quantitative model outputs, not investment recommendations. IBEX Limited's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

Frequently Asked Questions

Should I buy IBEX stock right now?

Based on CirclFi's multi-model analysis, 5 of 13 models see upside for IBEX at $35.39. The models are divided, which means the investment case depends heavily on your assumptions about IBEX Limited's future. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in IBEX Limited?

Key risks include: wide model disagreement (2063% spread), signaling high uncertainty; general market and sector-specific risks affecting Information Technology Services companies. Always diversify and consult a financial advisor.

How does IBEX compare to its competitors?

Among Information Technology Services peers, IBEX holds a Quality Score of 9.9/10. Comparable companies include EXLS (QOC 10.0), INOD (QOC 10.0), G (QOC 10.0). The relative ranking helps investors identify whether IBEX offers better fundamental quality than alternatives in the same sector.

Is IBEX a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. IBEX's Quality Score of 9.9/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.

What price should I buy IBEX at?

CirclFi does not provide target buy prices or price alerts. However, our 13 active models produce fair value estimates ranging from $8.26 to $178.70. At $35.39, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for IBEX.

View IBEX Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →